CHvCHCH3), 1.41 (s, 9H, C(CH3)3); 5f′, 6.22 (d, J = 14.1 Hz,
2H, 2 × CHvCHCH3), 5.31–5.19 (m, 2H, 2 × CHvCHCH3),
1.60 (d, J = 6.6 Hz, 6H, 2 × CHvCHCH3), 1.41 (s, 9H,
C(CH3)3); 13C NMR (75 MHz, CDCl3) δ 152.4, 133.1, 127.8,
127.0, 115.7, 115.2, 103.6, 81.0, 80.8, 46.5, 28.3, 15.4, 15.2.
2H, NCH2CvCH2), 3.80 (s, 3H, OMe), 3.79 (s, 3H, OMe),
3.03 (bs, 1H, COCH), 1.93–1.72 (m, 2H, CHCH2CH3), 0.89
(t, J = 7.3 Hz, 3H, CHCH2CH3); 13C NMR (75 MHz, CDCl3)
δ 174.8, 160.6, 158.7, 142.1, 130.9, 116.9, 108.3, 104.3, 98.4,
55.4 (2 × C), 51.6, 47.7, 40.4, 24.0, 9.7; IR (neat) 2962, 2930,
2854, 1693, 1663, 1613, 1589 cm−1
; Anal. Calcd for
1-(2,4-Dimethoxybenzyl)-3-methyl-4-methylidenepyrrolidin-2-
one (2g). Following general procedure for cycloisomerization,
starting with 1g (100 mg, 0.383 mmol) after 16 h and purifi-
cation through silica gel chromatography (Hex–AcOEt 4 : 1,
Rf = 0.60 for 2g and Rf = 0.55 for 2g′, both in Hex–AcOEt 1 : 1)
2g (45 mg, 0.17 mmol, 45%) and 2g′ (12 mg, 0.045 mmol,
C16H21NO3: C, 69.79; H, 7.69; N, 5.09. Found: C, 69.89; H,
7.72; N, 5.03.
Data for (E)-N-allyl-N-(2,4-dimethoxybenzyl)but-2-enamide,
(7). 1H NMR (300 MHz, DMSO-d6, 80 °C) δ 6.99 (d, J =
8.4 Hz, 1H, Ar), 6.75–6.65 (m, 1H, CHvCHCH3), 6.56 (d, J =
2.3 Hz, 1H, Ar), 6.49 (dd, J1 = 8.4 Hz, J2 = 2.3 Hz, 1H, Ar),
6.36 (dd, J1 = 14.9 Hz, J2 = 1.5 Hz, 1H, CHvCHCH3),
5.78–5.71 (m, 1H, CH2CHvCH2), 5.11–5.04 (m, 2H,
CH2CHvCH2) 4.44 (s, 2H, ArCH2N), 3.92 (AB system, 2H,
CH2CHvCH2), 3.79 (s, 3H, OMe), 3.76 (s, 3H, OMe),
1.83 (dd, J1 = 6.8 Hz, J2 = 1.6 Hz, 3H, CH3); 13C NMR
(75 MHz, CDCl3) 2 conformers δ 167.1, 160.4, 160.2, 158.0,
141.8, 141.8, 133.5, 133.4, 130.6, 127.9, 122.1, 117.5, 117.0,
116.3, 104.3, 103.9, 98.6, 98.3, 55.4, 55.2, 49.6, 48.2, 45.4,
43.2, 18.2;
1
12%) were obtained as pale yellow oils. H NMR (300 MHz,
CDCl3) δ 7.13 (d, J = 8.8 Hz, 1H, Ar), 6.46–6.44 (m, 2H, Ar),
5.03–5.00 (m, 2H, CvCH2), 4.48 (s, 2H, CH2Ar), 3.90–3.77
(m, 2H, NCH2CvCH2), 3.81 (s, 3H, OMe), 3.80 (s, 3H, OMe),
3.05 (q, J = 7.3 Hz, 1H, CHCH3), 1.32 (d, J = 7.3 Hz, 3H,
CHCH3); 13C NMR (75 MHz, CDCl3) δ 175.7, 160.8, 159.0,
144.6, 131.2, 117.1, 108.0, 104.5, 98.7, 55.7, 55.7, 51.6, 41.8,
40.7, 15.8; IR (neat) 2924, 2851, 1711, 1649, 1615, 1589 cm−1
;
Anal. Calcd for C15H19NO3: C, 68.94; H, 7.33; N, 5.36. Found:
C, 69.03; H, 7.24; N, 5.33.
1-(2,4-Dimethoxybenzyl)-4-methyl-3-methylidenepyrrolidin-2-
one (2g′). 1H NMR (300 MHz, CDCl3) δ 7.16 (d, J = 8.8 Hz,
1H, Ar), 6.47–6.43 (m, 2H, Ar), 6.00 (d, J = 2.4 Hz, 1H,
CvCHa), 5.27 (d, J = 2.4 Hz, 1H, CvCHb), 4.56 (d, J =
14.6 Hz, 1H, CHaAr), 4.48 (d, J = 14.6 Hz, 1H, CHbAr),
3.81 (s, 3H, OMe), 3.81 (s, 3H, OMe), 3.45 (t, J = 7.8 Hz,
Data for (E)-N-(2,4-dimethoxybenzyl)-N-((E)-prop-1-enyl)but-
2-enamide, (8). 1H NMR (300 MHz, DMSO-d6, 80 °C) δ 6.96
(d, J = 13.6 Hz, 1H, NCHvCHCH3), 6.83–6.75 (m, 1H,
CHvCHCH3), 6.77 (d, J = 10.9 Hz, 1H, CHvCHCH3), 6.57
(d, J = 2.4 Hz, 1H, Ar), 6.47 (d, J = 8.4 Hz, 1H, Ar), 6.49 (dd,
J1 = 8.4 Hz, J2 = 2.5 Hz, 1H, Ar), 5.01–4.90 (m, 1H,
NCHvCHCH3), 4.68 (s, 2H, ArCH2N), 3.82 (s, 3H, OMe),
3.75 (s, 3H, OMe), 1.85 (dd, J1 = 6.8 Hz, J2 = 1.6 Hz, 3H,
CH3), 1.62 (dd, J1 = 6.6 Hz, J2 = 1.6 Hz, 3H, CH3); 13C NMR
(75 MHz, CDCl3) 2 conformers δ 169.8, 157.7, 157.3, 143.3,
129.3, 127.2, 126.8, 122.2, 117.7, 116.8, 110.6, 107.1, 104.1,
98.4, 55.4, 55.3, 44.2, 18.3, 15.5.
1H, NCHaCvCH2), 2.92–2.80 (m, 2H, NCHbCvCH2
&
NCH2CH), 1.18 (d, J = 6.4 Hz, 3H, CHCH3); IR (neat) 2921,
2858, 1645, 1589, 1507 cm−1; Anal. Calcd for C15H19NO3: C,
68.94; H, 7.33; N, 5.36. Found: C, 68.79; H, 7.40; N, 5.25.
(1E)-1-(prop-2-en-1-ylsulfonyl)prop-1-ene (5h).32 Following
general procedure for cycloisomerization, starting with 1h
(100 mg, 0.68 mmol) after 3 h was obtained after silica gel
chromatography (Hex–AcOEt 4 : 1, Rf = 0.43 in Hex–AcOEt
2 : 1) 5h (90 mg, 0.61 mmol, 90%) was obtained as colorless oil.
1H NMR (300 MHz, CDCl3) δ 6.96–6.82 (m, 1H, CHCH3),
Diethyl 3,4-dimethylenecyclopentane-1,1-dicarboxylate (11a)33.
Following general procedure for cycloisomerization, starting
with 10a (100 mg, 0.42 mmol) after 20 min 11a (80 mg,
0.34 mmol, 80%) was obtained after silica gel chromatography
(Hex–AcOEt 20 : 1, Rf = 0.42 in Hex–AcOEt 6 : 1) as pale
yellow oil. 1H NMR (300 MHz, CDCl3) δ 5.38 (s, 2H, 2 ×
CvCHa), 4.95 (s, 2H, 2 × CvCHb), 4.19 (q, J = 7.2 Hz, 4H, 2
× OCH2CH3), 3.03 (s, 4H, 2 × CCH2C), 1.24 (t, J = 7.0 Hz, 6H,
2 × OCH2CH3); Anal. Calcd for C13H18NO4: C, 65.53; H, 7.61.
Found: C, 65.42; H, 7.53.
6.30 (apparent dd, J1
= 15.1 Hz, J2 = 1.6 Hz, 1H,
SO2CHvCH), 5.94–5.88 (m, 1H, CH2CHvCH2), 5.51 (d, J =
10.2 Hz, 1H, CH2CHvCH2), 5.44 (d, J = 17.0 Hz, 1H,
CH2CHvCH2), 3.71 (AB system, 2H, CH2CHvCH2), 1.97 (dd,
J1 = 6.7 Hz, J2 = 1.6 Hz, 3H, CHvCHCH3); 13C NMR
(75 MHz, CDCl3) δ 145.7, 128.6, 124.9, 124.4, 59.4, 17.4. IR
(neat) 2975, 2922, 1640 cm−1; Anal. Calcd for C6H10O2S: C,
49.29; H, 6.89. Found: C, 49.38; H, 6.80.
(3,4-Dimethylenecyclopentane-1,1-diyl)bis(methylene)bis(oxy)-
bis(tert-butyldimethylsilane) (11b). Following general procedure
for cycloisomerization, starting with 10b (100 mg, 0.26 mmol)
after 20 min 11b (63 mg, 0.16 mmol, 63%) was obtained after
silica gel chromatography (hexane, Rf = 0.62 in hexane) as color-
1-(2,4-Dimethoxybenzyl)-3-ethyl-4-methylenepyrrolidin-2-one
(9). Following general procedure for cycloisomerization, starting
with 6 (100 mg, 0.68 mmol) after 16 h 9 was obtained after
silica gel chromatography (Hex–AcOEt 6 : 1 to 2 : 1, Rf = 0.23 in
Hex–AcOEt 2 : 1) (38 mg, 0.25 mmol, 38%) as a brown oil and
55 mg of a mixture of 7 + 8 which was separated by column
chromatography (Hex–AcOEt 6 : 1) to give 15 mg of 7 (15%)
1
less oil. H NMR (300 MHz, CDCl3) δ 5.34 (s, 2H, CvCH2),
4.83 (s, 2H, CvCH2), 3.39 (s, 4H, 2 × CH2O), 2.26 (s, 4H,
2 × CH2), 0.87 (s, 18H, 2 × C(CH3)3), 0.00 (s, 12H, 2 ×
(CH3)2Si)); 13C NMR (75 MHz, CDCl3) δ 147.8, 104.6, 64.7,
47.0, 38.6, 25.9, 18.3, −5.5; IR (neat) 2955, 2930, 2857,
1676 cm−1; Anal. Calcd for C21H42O2Si2: C, 65.90; H, 11.06.
Found: C, 65.73; H, 11.19.
1
and 35 mg of 8 (35%) as colorless oils. Data for 9: H NMR
(300 MHz, CDCl3) δ 7.12 (d, J = 9.1 Hz, 1H, Ar), 6.46–6.42
(m, 2H, Ar), 5.05–5.01 (m, 2H, CvCH2), 4.57 (d, J = 14.5 Hz,
1H, CHaAr), 4.39 (d, J = 14.6 Hz, 1H, CHbAr), 3.82–3.67 (m,
This journal is © The Royal Society of Chemistry 2012
Org. Biomol. Chem., 2012, 10, 6665–6672 | 6671